Bladder Cancer Clinical Trial
Efficacy and Utility of Cxbladder Tests in Hematuria Patients
Summary
Prospective observational study to validate the performance characteristics and clinical utility of Cxbladder tests in a Veterans Affairs cohort.
Full Description
Non-invasive, voided urine sample used for both Cxbladder molecular tests, voided urine sample may be used for standard of care testing. Retrospective analysis of data after study completion ensures a de-phasing of study sample analysis from clinical decision making; patient treatment and management.
The study aims to sequentially recruit up to 1000 patients presenting for assessment of hematuria (microscopic or macroscopic) by cystoscopy across multiple Veterans Affairs sites
Eligibility Criteria
Inclusion Criteria:
Patient is undergoing investigation of recent confirmed hematuria (by either flexible or rigid cystoscopy/TURBT), including hematuria patients referred due to suspicious/positive imaging, in order to determine the presence of urothelial carcinoma.
Able to provide a voided urine sample of the required minimum volume
Able to give written consent
Able and willing to comply with study requirements
Aged 18 years or older
Exclusion Criteria:
Prior history of bladder malignancy, prostate or renal cell carcinoma
Prior genitourinary manipulation (flexible or rigid cystoscopy / catheterisation, urethral dilation) in the 14 days before urine collection
Previous alkylating based chemotherapy
Known Pregnancy.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 10 Locations for this study
San Diego California, 92161, United States
Bay Pines Florida, 33744, United States
Miami Florida, 33125, United States
Tampa Florida, 33612, United States
Minneapolis Minnesota, 55417, United States
Omaha Nebraska, 68105, United States
New York New York, 10468, United States
Oklahoma City Oklahoma, 73104, United States
Charleston South Carolina, 29401, United States
White River Junction Vermont, 05009, United States
How clear is this clinincal trial information?